Results 41 to 50 of about 136,614 (358)

Using the quantitative determination of HBsAg to predict the course of chronic hepatitis B in women during pregnancy and after childbirth

open access: yesЖурнал инфектологии, 2014
This study is based on the investigation of 31 HB V-infected women, which have observed at Botkin Infectious Hospital in 2012. Considerable variations of viral load in the course of pregnancy have been observed in the HB V cohort.
M. A. Belopolskaya   +3 more
doaj   +1 more source

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas [PDF]

open access: yes, 1996
This paper uses meta-analysis of published data and a deterministic mathematical model of hepatitis B virus (HBV) transmission to describe the patterns of HBV infection in high endemicity areas.
A. J. Hall   +20 more
core   +2 more sources

Persistence of HBsAg‐specific antibodies and immune memory two to three decades after hepatitis B vaccination in adults

open access: yesJournal of Viral Hepatitis, 2019
The duration of protection after hepatitis B vaccination is not exactly known. This phase IV study evaluated antibody persistence and immune memory 20‐30 years after adult immunization with recombinant hepatitis B vaccine (HBsAg vaccine, Engerix‐B) in ...
P. van Damme   +7 more
semanticscholar   +1 more source

Clinical, epidemiological and virological features of acute hepatitis B in Italy [PDF]

open access: yes, 2015
Purpose To evaluate the association of hepatitis B virus (HBV) genotypes, basal core promoter (BCP)/precore (PC) and S gene mutations with the clinical-epidemiological characteristics of acute hepatitis B (AHB) in Italy.
Alessandro Remo Zanetti   +10 more
core   +1 more source

Seven-Year Treatment Outcome of Entecavir in a Real-World Cohort: Effects on Clinical Parameters, HBsAg and HBcrAg Levels

open access: yesClinical and Translational Gastroenterology, 2017
Objectives:We aimed to determine the levels of alanine aminotransferase (ALT), hepatitis B virus DNA (HBV DNA), HBsAg, and a novel viral marker (hepatitis B core-related antigen (HBcrAg)); hepatitis B e antigen (HBeAg) seroconversion and drug resistance ...
Yuk‐Fai Lam   +9 more
semanticscholar   +1 more source

HBsAg sT123N mutation induces stronger antibody responses to HBsAg and HBcAg and accelerates in vivo HBsAg clearance

open access: yesVirus Research, 2015
Immune escape mutants with mutations in the hepatitis B surface antigen (HBsAg) major hydrophilic region (MHR) often emerge in association with diagnostic failure or breakthrough of HBV infection in patients with anti-HBs antibodies. Some mutants harboring substitutions to Asn in HBsAg MHR may have an additional potential N-glycosylation site.
Li, Songxia   +11 more
openaire   +2 more sources

The possible impact of sortilin in reducing HBsAg expression in chronic hepatitis B [PDF]

open access: yes, 2016
Hepatitis B virus (HBV) infection is a major global health problem. Chronically infected people are at risk for progressive hepatic fibrosis and consequent cirrhosis.
Besharat, S.   +6 more
core  

The prevalence of occult hepatitis B virus (hbv) infection in a large multi-ethnic haemodialysis cohort. [PDF]

open access: yes, 2015
Haemodialysis patients are at increased risk of exposure to blood borne viruses. To reduce transmission in the UK, all haemodialysis patients are regularly screened, and if susceptible to Hepatitis B virus (HBV) infection ...
Cross, J   +6 more
core   +1 more source

Lactylated SPTAN1 Accelerates Hepatocellular Carcinoma Progression by Promoting NOTCH1/HES1 Activation and Immunosuppression

open access: yesAdvanced Science, EarlyView.
This study identifies SPTAN1‐kla as a novel oncogenic driver in HBV‐driven HCC, linking metabolic, epigenetic, and immune mechanisms. SPTAN1‐kla promotes HCC progression via NOTCH1/HES1 activation and immunosuppression. Findings highlight that targeting SPTAN1‐kla provides a framework for HCC treatment to improve clinical outcomes in HBV infected ...
Zengbin Wang   +8 more
wiley   +1 more source

Renal transplantation from HBsAg positive donors to HBsAg negative recipients. [PDF]

open access: yesBMJ, 1988
4 cas de transplantation renale ou le donneur est positif pour l'antigene de surface et l'anticorps, le receveur negatif. Dans les 4 cas les receveurs presentent apres 1 an ou plus les anticorps mais non l'antigene, et la fonction hepatique reste normale.
A A, al-Khader   +3 more
openaire   +5 more sources

Home - About - Disclaimer - Privacy